MIRO insider filings

Miromatrix Medical Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-12-13. Screen MIRO transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for MIRO between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Miromatrix Medical Inc.

FiledFormInsiderReported transactionsSource
2023-12-134Maag Peter — DirectorCode (U): 62,092 · Disposition to issuer (D): 58,368EDGAR
2023-12-134Burke William P. Mr. — DirectorCode (U): 66,943 · Disposition to issuer (D): 67,413EDGAR
2023-12-134Douglas James Michael — CHIEF FINANCIAL OFFICERCode (U): 31,250 · Disposition to issuer (D): 20,000 · Disposition to issuer (D): 180,000 (derivative) · Disposition to issuer (D): 40,000 (derivative)EDGAR
2023-12-134Heine Lisa Wipperman — DirectorCode (U): 66,943 · Disposition to issuer (D): 67,413EDGAR
2023-12-134Ross Jeffrey James — CHIEF EXECUTIVE OFFICER, DirectorCode (U): 308,775 · Disposition to issuer (D): 87,500 · Disposition to issuer (D): 41,250 (derivative) · Disposition to issuer (D): 43,750 (derivative) · Disposition to issuer (D): 33,688 (derivative) · Disposition to issuer (D): 39,375 (derivative) · +5 moreEDGAR
2023-12-134BUCKMAN PAUL — DirectorCode (U): 52,593 · Disposition to issuer (D): 54,201 · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 18,750 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · +1 moreEDGAR
2023-12-134ERB JOHN L — DirectorCode (U): 56,260 · Disposition to issuer (D): 54,201 · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 18,750 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · +1 moreEDGAR
2023-06-054Heine Lisa Wipperman — DirectorGrant/award (A): 54,201 @ $0EDGAR
2023-06-054Burke William P. Mr. — DirectorGrant/award (A): 54,201 @ $0EDGAR
2023-06-054Maag Peter — DirectorGrant/award (A): 54,201 @ $0EDGAR
2023-06-054BUCKMAN PAUL — DirectorGrant/award (A): 54,201 @ $0EDGAR
2023-06-054ERB JOHN L — DirectorGrant/award (A): 54,201 @ $0EDGAR
2023-03-304Douglas James Michael — CHIEF FINANCIAL OFFICERPurchase (P): 31,250 @ $1.60EDGAR
2023-03-304Ross Jeffrey James — CHIEF EXECUTIVE OFFICER, DirectorPurchase (P): 31,250 @ $1.60EDGAR
2023-03-304Barry John Joseph — VICE PRESIDENT OF R&DPurchase (P): 6,250 @ $1.60EDGAR
2023-03-304Maag Peter — DirectorPurchase (P): 31,250 @ $1.60EDGAR
2023-03-304Burke William P. Mr. — DirectorPurchase (P): 31,250 @ $1.60EDGAR
2023-03-304Heine Lisa Wipperman — DirectorPurchase (P): 31,250 @ $1.60EDGAR
2023-03-304BUCKMAN PAUL — DirectorPurchase (P): 31,250 @ $1.60EDGAR
2023-03-304ERB JOHN L — DirectorPurchase (P): 31,250 @ $1.60EDGAR
2023-01-184Ross Jeffrey James — CHIEF EXECUTIVE OFFICER, DirectorGrant/award (A): 50,000 @ $0 · Tax withholding (F): 4,487 @ $3.26 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-01-184Barry John Joseph — VICE PRESIDENT OF R&DGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2023-01-184Douglas James Michael — CHIEF FINANCIAL OFFICERGrant/award (A): 20,000 @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2022-12-084Ross Jeffrey James — CHIEF EXECUTIVE OFFICER, DirectorOption exercise (M): 37,500 @ $1.25 · Tax withholding (F): 11,575 @ $4.05 · Option exercise (M): 37,500 (derivative) @ $0EDGAR
2022-10-044Barry John Joseph — VICE PRESIDENT OF R&DTax withholding (F): 765 @ $4.38EDGAR
2022-08-164Maag Peter — DirectorGrant/award (A): 12,788 @ $0EDGAR
2022-08-164Heine Lisa Wipperman — DirectorGrant/award (A): 12,788 @ $0EDGAR
2022-08-164Burke William P. Mr. — DirectorGrant/award (A): 12,788 @ $0EDGAR
2022-08-164BUCKMAN PAUL — DirectorGrant/award (A): 12,788 @ $0EDGAR
2022-08-164ERB JOHN L — DirectorGrant/award (A): 12,788 @ $0EDGAR
2022-03-174Ross Jeffrey James — CHIEF EXECUTIVE OFFICER, DirectorOption exercise (M): 35,438 @ $1.25 · Option exercise (M): 35,438 (derivative) @ $0EDGAR
2022-03-024Douglas James Michael — Chief Financial OfficerGrant/award (A): 180,000 (derivative) @ $0EDGAR
2022-01-184Barry John Joseph — VICE PRESIDENT OF R&DGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-01-184Kattungal Laji — VICE PRESIDENT OF QUALITYGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-01-184Ross Jeffrey James — CHIEF EXECUTIVE OFFICER, DirectorGrant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-01-184/ARoss Jeffrey James — CHIEF EXECUTIVE OFFICER, DirectorConversion (C): 4,400 @ $0 · Conversion (C): 4,400 (derivative)EDGAR
2022-01-184NIEBUR BRIAN — CHIEF FINANCIAL OFFICERGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-01-054Ross Jeffrey James — Chief Executive Officer, DirectorGrant/award (A): 1,500 (derivative) @ $0EDGAR
2022-01-054Kattungal Laji — Vice President of QualityGrant/award (A): 1,500 (derivative) @ $0EDGAR
2022-01-054Barry John Joseph — Vice President of R&DGrant/award (A): 1,500 (derivative) @ $0EDGAR
2022-01-054Heine Lisa Wipperman — DirectorGrant/award (A): 4,405 @ $0 · Grant/award (A): 31,712 @ $0EDGAR
2022-01-054Burke William P. Mr. — DirectorGrant/award (A): 4,405 @ $0 · Grant/award (A): 31,712 @ $0EDGAR
2022-01-054NIEBUR BRIAN — Chief Financial OfficerGrant/award (A): 1,500 (derivative) @ $0EDGAR
2021-10-054Barry John Joseph — Vice President of R&DGrant/award (A): 10,000 @ $0 · Grant/award (A): 70,000 (derivative) @ $0EDGAR
2021-10-054NIEBUR BRIAN — Chief Financial OfficerGrant/award (A): 8,000 @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2021-06-294NIEBUR BRIAN — Chief Financial OfficerConversion (C): 3,334 · Conversion (C): 3,334 · Conversion (C): 3,334 (derivative) · Conversion (C): 3,334 (derivative)EDGAR
2021-06-294BUCKMAN PAUL — DirectorConversion (C): 3,000 · Conversion (C): 3,000 (derivative)EDGAR
2021-06-294ERB JOHN L — DirectorConversion (C): 6,667 · Conversion (C): 6,667 (derivative)EDGAR
2021-06-294WAGNER MARK T — DirectorConversion (C): 3,334 · Conversion (C): 3,334 (derivative)EDGAR
2021-06-294EIBENSTEINER RONALD E — DirectorConversion (C): 59,769 · Conversion (C): 120,000 · Conversion (C): 20,000 · Conversion (C): 59,769 (derivative) · Conversion (C): 20,000 (derivative) · Conversion (C): 120,000 (derivative)EDGAR

Recent 8-K events — Miromatrix Medical Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-12-188-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-10-308-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-08-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-06-028-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2023-06-018-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-318-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-088-K1.01 — Entry into a Material Definitive Agreement
2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-018-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=MIRO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs